Mesa Laboratories Inc MLAB Q1 2026 Earnings Strong EPS Surprise of 130 Amid Quiet Revenue Disclosure IO Biotech Q3 2025 Earnings EPS Beat of 6067 Surprise but No Revenue from PreCommercial Pipeline CMI Q1 2026 Earnings EPS Beat of 897 Surprises Analysts WSO Q1 2026 Earnings EPS Surpasses Estimates by 933 Stock Declines Marginally SFB Q1 2026 Earnings Slight EPS Beat on Core Operations Gladstone Investment Corporation GAINN Q1 2026 Earnings EPS Misses Estimates by 88 as Investment Income Pressures Persist